title: Further inquiry into treating hepatitis C with recombinant interferon alpha.
authors.forename: C
authors.initials: C
authors.lastname: Puoti
authors.forename: B
authors.initials: B
authors.lastname: Fuiano
authors.forename: G
authors.initials: G
authors.lastname: Annovazzi
authors.forename: A
authors.initials: A
authors.lastname: Pannullo
authors.forename: F
authors.initials: F
authors.lastname: Patane
mesh_terms: D015415:Biomarkers / Q000097:blood; D002908:Chronic Disease; D004351:Drug Resistance; D006509:Hepatitis B / Q000150:complications* / Q000276:immunology; D006510:Hepatitis B Antibodies / Q000032:analysis / Q000276:immunology; D006515:Hepatitis B virus / Q000276:immunology; D006526:Hepatitis C / Q000150:complications / Q000628:therapy*; D006521:Hepatitis, Chronic / Q000209:etiology / Q000628:therapy*; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000150:complications*; D011379:Prognosis; D011994:Recombinant Proteins; D012008:Recurrence
chemical_list: D015415:Biomarkers; D006510:Hepatitis B Antibodies; D007370:Interferon Type I; D011994:Recombinant Proteins